CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript
CareDx, Inc beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.24.
Caredx Inc. (CDNA)
Market is closed
Sector: Services-Medical Laboratories
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 5,864,046 | $62,100,244 | -19% | 0.42% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $42.34 | 5,000 | Officer | 5,000 | 2021-11-24 | Filing | |
| $47.62 | 600 | Director | 2,855 | 2021-11-05 | Filing | |
| $9.42 | 10,136 | Large Shareholder | 965,894 | 2018-04-26 | Filing | |
| $4.00 | 1,278 | Large Shareholder | 40,529 | 2017-10-05 | Filing | |
| $4.00 | 9,364 | Large Shareholder | 928,768 | 2017-10-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.91 | 2,818 | Officer, Director | 479,164 | 2023-10-02 | Filing | |
| $9.49 | 2,819 | Officer, Director | 481,982 | 2023-09-05 | Filing | |
| $8.89 | 576 | Officer, Director | 484,801 | 2023-08-14 | Filing | |
| $10.56 | 86 | Officer, Director | 486,051 | 2023-08-02 | Filing | |
| $11.37 | 2,733 | Officer, Director | 486,137 | 2023-08-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,543,666 | $66,523,992 | 0% | |
| 2. | 4,119,682 | $49,436,184 | 0% | |
| 3. | 3,954,792 | $47,457,504 | 0.72% | |
| 4. | 2,874,899 | $34,498,788 | 0.33% | |
| 5. | 2,874,899 | $34,498,788 | 0.02% |
News See All
CareDx, Inc (NASDAQ:CDNA) Q3 2023 Earnings Call Transcript
Operator: Good day, everyone, and welcome to today's CareDx Inc. Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
CareDx, Inc (NASDAQ:CDNA) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the CareDx, Incorporated Second Quarter 2023 Earnings Conference Call.
CareDx, Inc (NASDAQ:CDNA) Q1 2023 Earnings Call Transcript
Operator: Greetings. And welcome to the CareDx, Inc. First Quarter 2023 Earnings Conference Call. During the presentation, all participants will be in a listen-only mode.
Should You Exit CareDx (CDNA)?
Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
CareDx, Inc (NASDAQ:CDNA) Q4 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the CareDx, Incorporated Fourth Quarter 2022 Earnings Conference Call. Today's conference is being recorded.
Baron Discovery Fund Believes CareDx (CDNA) Will Reward Investors for Patience
Baron Funds, an investment management company, released its “Baron Discovery Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
13 Best Genomics Stocks To Buy Now
Before talking about the best genomics stocks, it is important to understand what the term actually means.
Do You Think CareDx (CDNA) Has Huge Growth Potential?
Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2022 investor letter. A copy of the same can be downloaded here.
Cathie Wood's Top 15 Small-Cap Stock Picks
In this article, we discuss the 10 small-cap stock picks of Cathie Wood’s 2022 portfolio.